Shanghai Bio-heart Biological Technology Co., Ltd. (BIOHEART-B, 02185) released its monthly return for the period ended 28 February 2026. The total authorized share capital remained at 243.42 million shares, comprising 235.70 million H shares and 7.71 million unlisted foreign shares, each at a par value of RMB1.

During the period, no changes were recorded in the issued shares or treasury shares. The company affirmed that its public float continues to meet the required threshold of 25%. No new share options, warrants, or convertible securities were issued in the reporting month.